Please sign in to follow a disease.
Can rice water and eggs fight cancer wasting? new study tests cheap remedy
NCT ID NCT07613125
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a simple, low-cost drink made from rice starch water, egg, and multivitamins can help cancer patients with cachexia—a condition causing severe weight loss and muscle wasting. The trial will involve 106 patients in Bangladesh, half receiving the supplement for 14 days alongside standard care, and the other half receiving only standard care. Researchers will measure changes in blood markers like albumin and hemoglobin, as well as quality of life.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- rice starch water with egg and multivitamin multimineral
- What this could lead to
- If it works, this could offer an affordable, locally available way to improve nutrition and quality of life for cancer patients with cachexia in low-income settings.
- What could go wrong
- This is a small, early-stage study with no blinding or randomization, so results may be unreliable. The supplement is simple and may not be enough to reverse cachexia.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 106 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2026
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Age- ≥18 years. 2. Either sex 3. Diagnosed case of cancer who met Fearon et al's criteria for cancer cachexia. 4. Informed written consent. Exclusion Criteria: 1. Patients with severe organ dysfunction, such as: renal failure (chronic kidney disease stage 4 and above), advanced hepatic failure (child-pugh score class B or C), severe cardiac dysfunction (heart failure, arrythmia, acute coronary syndrome). 2. Patient with stage 4 (metastasis) cancer 3. Patients with active gastrointestinal obstruction or any complication that will interfere with oral and tube feeding. 4. Patient who are already getting commercially available nutritional formula or multivitamin, multimineral therapy. 5. Patients with a recent history (e.g., \<3 months) of participation in another nutritional intervention study. 6. Patients who require exclusive parenteral feeding. 7. Patients with a known allergy to egg protein
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cancer cachexia (CC) are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institute of Cancer Research & Hospital (NICRH)
Dhaka, Mohakhali, 1212, Bangladesh
More trials for these conditions
Other studies related to the condition(s) this trial covers.